Advertisement

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

First International Summit on Interventional Pharmacoeconomics

Advertisement

Related Videos

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Advertisement

Advertisement

Mar

24

Today In Oncology

ASH 2025: Myelofibrosis Roundup

AI Model Classifies Challenging Thymic Epithelial Tumors

Awareness of Alcohol-Cancer Link Holds Steady Despite Omission in New US Dietary Guidelines

Study Finds Inferior Survival Among Black Patients With AML, Independent of Cytogenetic Risk

Lisocabtagene Maraleucel in Relapsed or Refractory MZL

Advertisement

© 2026 HSP News Service, L.L.C.